A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee
Status:
Withdrawn
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness of CF101 in treating the symptoms of osteoarthritis
(OA) of the knee. Eligible patients will be given either CF101 or matching placebo tablets
and their symptoms will be evaluated over the 12 week treatment period.